NFKB1 and endothelial dysfunction: It disables NF-κB via PKC- and PI3K/Akt-mediated Nrf2 activation in human dermal microvascular endothelial cells (HMEC-1), preventing lipopolysaccharide-evoked endothelial dysfunction from acute inflammation [30].